Clinical trial
A Prospective, Multi-center, Randomized Controlled Trial Evaluating the Safety and Efficacy of the CRE8 Sirolimus-Eluting Stent Versus the RESOLUTE Zotarolimus-Eluting Stent in the Treatment of Patients With De Novo Coronary Artery Lesions
NCT02360423 is registered in ClinicalTrials.gov with CID S.p.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-center, Randomized Controlled Trial Evaluating the Safety and Efficacy of the CRE8 Sirolimus-Eluting Stent Versus the RESOLUTE Zotarolimus-Eluting Stent in the Treatment of Patients With De Novo Coronary Artery Lesions
- Lead sponsor
- CID S.p.A.
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- November 30, 2014
- Completion date
- April 30, 2021
- Enrollment
- 430 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.